Enlivex ENLV
NASDAQ ENLV
$1.50 -0.23 (-13.29%)
At close: Aug 20, 2026 · 4:00 PM EDT

Enlivex (ENLV) Revenue (2022 - 2025)

Enlivex (ENLV) posted quarterly Revenue of -$3.8 million for Q1 2025, up 17.96% year-over-year from -$3.2 million in Q1 2024, and down 134.17% quarter-over-quarter from $11.2 million in Q4 2024.

Enlivex (ENLV) Revenue (2022 - 2025) Analysis & Trends

Enlivex's Revenue history runs 4 years deep, the most recent figure standing at -$3.8 million for Q1 2025.

  • In Q1 2025, Revenue rose 17.96% year-over-year to -$3.8 million; the TTM figure through Mar 2025 stood at $24.6 million (up 1748.16% YoY), while the FY2024 annual figure was -$36.9 million, down 25.27% from the prior year.
  • Revenue for Q1 2025 stood at -$3.8 million, down from $11.2 million in the prior quarter.
  • The five-year high for Revenue was $21.9 million in Q4 2023, with the low at -$8.2 million in Q1 2022.
  • The 4-year median for Revenue is -$4.2 million (2024), against an average of $1.4 million.
  • Peak annual rise in Revenue reached 39.4% in 2024, while the deepest fall reached 48.97% in 2024.
  • Enlivex's Revenue stood at -$8.2 million in 2022, then jumped by 366.0% to $21.9 million in 2023, then slumped by 48.97% to $11.2 million in 2024, then tumbled by 134.17% to -$3.8 million in 2025.
  • Business Quant data shows ENLV's Revenue at -$3.8 million in Q1 2025, $11.2 million in Q4 2024, and -$4.7 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.52 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.29 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 425.49 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 674.14 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 1.06 Bn
10 Enlivex 4.58 Mn -1.17 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 -3.82 Mn
Dec 31, 2024 11.17 Mn
Mar 31, 2024 -4.65 Mn
Dec 31, 2023 21.90 Mn
Mar 31, 2023 -7.68 Mn
Mar 31, 2022 -8.23 Mn